Sanofi Q3 well on track
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St mixed as investors assess softer jobs data
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
BofA/Merrill Lynch Starts BioNTech (BNTX) at Buy
November 4, 2019 6:15 AM ESTBofA/Merrill Lynch initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.91 yesterday.
... MoreCanaccord Genuity Starts BioNTech (BNTX) at Buy
November 4, 2019 5:12 AM ESTCanaccord Genuity analyst Arlinda Lee initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $17.01 yesterday.
... More